Hepatitis C and general practice: the crucial role of primary care in stemming the epidemic

被引：0
作者：
Budd, J
Robertson, R
机构：
[1] Muirhouse Med Grp, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland
来源：
BRITISH JOURNAL OF GENERAL PRACTICE | 2005年 / 55卷 / 513期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：259 / 260
页数：2
相关论文
共 24 条
[11]   Estimating progression to cirrhosis in chronic hepatitis C virus infection [J].
Freeman, AJ ;
Dore, GJ ;
Law, MG ;
Thorpe, M ;
Von Overbeck, J ;
Lloyd, AR ;
Marinos, G ;
Kaldor, JM .
HEPATOLOGY, 2001, 34 (04) :809-816
[12]  
Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42
[13]  
*HLTH PROM AG, 2004, SHOOT UP INF INJ DRU
[14]   Treatment of acute hepatitis C with interferon alfa-2b [J].
Jaeckel, E ;
Cornberg, M ;
Wedemeyer, H ;
Santantonio, T ;
Mayer, J ;
Zankel, M ;
Pastore, G ;
Dietrich, M ;
Trautwein, C ;
Manns, MP .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1452-1457
[15]  
JOHNSON AM, 1990, AIDS POCKET BOOK DIA
[16]   Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].
Manns, MP ;
McHutchison, JG ;
Gordon, SC ;
Rustgi, VK ;
Shiffman, M ;
Reindollar, R ;
Goodman, ZD ;
Koury, K ;
Ling, MH ;
Albrecht, JK .
LANCET, 2001, 358 (9286) :958-965
[17]   Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C [J].
Poynard, T ;
Ratziu, V ;
Charlotte, F ;
Goodman, Z ;
McHutchison, J ;
Albrecht, J .
JOURNAL OF HEPATOLOGY, 2001, 34 (05) :730-739
[18]  
*ROY COLL PHYS ED, 2004, CONS C HEP C 21 22 A
[19]  
*SCOTT NEEDS ASS P, 2000, HEP C
[20]   Cost effectiveness of combination therapy for hepatitis C: a decision analytic model [J].
Stein, K ;
Rosenberg, W ;
Wong, J .
GUT, 2002, 50 (02) :253-258
123